aiqbench analysis
This research introduces a model-agnostic framework that integrates domain knowledge with self-supervised learning to significantly boost classification accuracy in weakly annotated bioimaging tasks. By improving precision across multiple architectures, the method addresses critical challenges in analyzing complex phenotypes like TDP-43 mislocalization for ALS research. The approach demonstrates how leveraging external knowledge can overcome limitations inherent in purely automated feature extraction pipelines.
Model-agnostic Knowledge Augmented Machine Learning for Weakly Annotated Bioimaging Data
arXiv:2610.13637v1 Announce Type: cross Abstract: Machine learning models are increasingly used for automated feature extraction from weakly annotated bioimaging data, such as microscopy and cytomorphology images. Due to the sole dependency of automated feature extraction, existing methods yield inconsistent classification performance across weakly annotated datasets. Here, we propose a model-agnostic knowledge augmentation method that enables ML models to exploit domain knowledge beyond what automated feature extraction can capture. The proposed approach improves classification performance across seven ML architectures. When integrated with masked autoencoder-based self-supervised learning, our method achieves the strongest overall performance, improving precision by 2.9% over the next-best method on three in-house microscopy datasets and by an average of 6.8% across three public cytomorphology benchmarks. We perform nucleus-level classification based on mislocalization of TAR DNA-binding protein 43 (TDP-43) from the nucleus to the cytoplasm, a phenotype linked to Amyotrophic Lateral Sclerosis (ALS), using three independent microscopy datasets of motor neurons derived from human induced pluripotent stem cells. Accurate quantification of this phenotype at scale remains challenging and may contribute to inconsistencies across studies. Application of the best-performing model to these microscopy datasets reveals biological interpretations related to ALS, including dose-dependent effects of the proteasomal stressor, MG132, and the oxidative stressor, sodium arsenite (SA), on TDP-43 mislocalization, variable pathology in motor neurons from sporadic and familial ALS donors, and a lack of protection of the pharmacological compounds, edaravone and niclosamide, against SA-induced TDP-43 mislocalization. Together, our pipeline enables in-vitro cellular image analysis to advance understanding of ALS-associated pathology and potential treatments.
Abstract:Machine learning models are increasingly used for automated feature extraction from weakly annotated bioimaging data, such as microscopy and cytomorphology images. Due to the sole dependency of automated feature extraction, existing methods yield inconsistent classification performance across weakly annotated datasets. Here, we propose a model-agnostic knowledge augmentation method that enables ML models to exploit domain knowledge beyond what automated feature extraction can capture. The proposed approach improves classification performance across seven ML architectures. When integrated with masked autoencoder-based self-supervised learning, our method achieves the strongest overall performance, improving precision by 2.9% over the next-best method on three in-house microscopy datasets and by an average of 6.8% across three public cytomorphology benchmarks. We perform nucleus-level classification based on mislocalization of TAR DNA-binding protein 43 (TDP-43) from the nucleus to the cytoplasm, a phenotype linked to Amyotrophic Lateral Sclerosis (ALS), using three independent microscopy datasets of motor neurons derived from human induced pluripotent stem cells. Accurate quantification of this phenotype at scale remains challenging and may contribute to inconsistencies across studies. Application of the best-performing model to these microscopy datasets reveals biological interpretations related to ALS, including dose-dependent effects of the proteasomal stressor, MG132, and the oxidative stressor, sodium arsenite (SA), on TDP-43 mislocalization, variable pathology in motor neurons from sporadic and familial ALS donors, and a lack of protection of the pharmacological compounds, edaravone and niclosamide, against SA-induced TDP-43 mislocalization. Together, our pipeline enables in-vitro cellular image analysis to advance understanding of ALS-associated pathology and potential treatments.
Image and Video Processing (eess.IV); Artificial Intelligence (cs.AI); Computer Vision and Pattern Recognition (cs.CV)
arXiv:2610.13637 [eess.IV]
(or arXiv:2610.13637v1 [eess.IV] for this version)
https://doi.org/10.48550/arXiv.2610.13637 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 351 words
Related coverage

Mastering Agentic Techniques: AI Agent Customization
NVIDIA · May 20, 2026

Presentation: From OTEL to SLMs: Distilling Frontier Model Behaviour from Production Telemetry
InfoQ · Jul 17, 2026
Ranking Prior Alignment for Credit Risk Modeling: When Do External Priors Matter?
arXiv · Oct 9, 2026

Reducing medical claims review time with AI on AWS: The EXL Medical IDP solution
AWS · Sep 21, 2026